Literature DB >> 16781738

Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration.

William M Doyon1, Elaina C Howard, Toni S Shippenberg, Rueben A Gonzales.   

Abstract

Our study examined ethanol self-administration and accumbal dopamine concentration during kappa-opioid receptor (KOPr) blockade. Long-Evans rats were trained to respond for 20 min of access to 10% ethanol (with sucrose) over 7 days. Rats were injected s.c. with the long-acting KOPr antagonist, nor-binaltorphimine (NOR-BNI; 0 or 20 mg/kg) 15-20 h prior to testing. Microdialysis revealed a transient elevation in dopamine concentration within 5 min of ethanol access in controls. NOR-BNI-treated rats did not exhibit this response, but showed a latent increase in dopamine concentration at the end of the access period. The rise in dopamine levels correlated positively with dialysate ethanol concentration but not in controls. NOR-BNI did not alter dopamine levels in rats self-administering 10% sucrose. The transient dopamine response during ethanol acquisition in controls is consistent with previous results that were attributed to ethanol stimulus cues. The altered dopamine response to NOR-BNI during ethanol drinking suggests that KOPr blockade temporarily uncovered a pharmacological stimulation of dopamine release by ethanol. Despite these neurochemical changes, NOR-BNI did not alter operant responding or ethanol intake, suggesting that the KOPr is not involved in ethanol-reinforced behavior under the limited conditions we studied.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781738      PMCID: PMC1973091          DOI: 10.1016/j.neuropharm.2006.04.005

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  44 in total

1.  Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats.

Authors:  I W Beczkowska; W D Bowen; R J Bodnar
Journal:  Brain Res       Date:  1992-09-04       Impact factor: 3.252

2.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.

Authors:  R Spanagel; A Herz; T S Shippenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

3.  Effect of dopamine agonists and antagonists on ethanol-reinforced behavior: the involvement of the nucleus accumbens.

Authors:  H H Samson; C W Hodge; G A Tolliver; M Haraguchi
Journal:  Brain Res Bull       Date:  1993       Impact factor: 4.077

4.  Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.

Authors:  M H Heijna; M Padt; F Hogenboom; P S Portoghese; A H Mulder; A N Schoffelmeer
Journal:  Eur J Pharmacol       Date:  1990-06-08       Impact factor: 4.432

5.  Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats.

Authors:  H H Samson
Journal:  Alcohol Clin Exp Res       Date:  1986-08       Impact factor: 3.455

6.  Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats.

Authors:  R Bals-Kubik; A Ableitner; A Herz; T S Shippenberg
Journal:  J Pharmacol Exp Ther       Date:  1993-01       Impact factor: 4.030

7.  Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo.

Authors:  T Endoh; H Matsuura; C Tanaka; H Nagase
Journal:  Arch Int Pharmacodyn Ther       Date:  1992 Mar-Apr

8.  Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release.

Authors:  P Leone; D Pocock; R A Wise
Journal:  Pharmacol Biochem Behav       Date:  1991-06       Impact factor: 3.533

9.  Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.

Authors:  A E Takemori; B Y Ho; J S Naeseth; P S Portoghese
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

10.  Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning.

Authors:  R F Mucha; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more
  38 in total

1.  Early role of the κ opioid receptor in ethanol-induced reinforcement.

Authors:  Ricardo Marcos Pautassi; Michael E Nizhnikov; Ma Belén Acevedo; Norman E Spear
Journal:  Physiol Behav       Date:  2012-01-11

Review 2.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

3.  Accumbens neurochemical adaptations produced by binge-like alcohol consumption.

Authors:  Karen K Szumlinski; Mahdi E Diab; Raquel Friedman; Liezl M Henze; Kevin D Lominac; M Scott Bowers
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

Review 4.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 5.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

6.  Accumbens Homer2 overexpression facilitates alcohol-induced neuroplasticity in C57BL/6J mice.

Authors:  Karen K Szumlinski; Alexis W Ary; Kevin D Lominac; Matthias Klugmann; Tod E Kippin
Journal:  Neuropsychopharmacology       Date:  2007-06-13       Impact factor: 7.853

7.  Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats.

Authors:  Angela Henderson-Redmond; Cristine Czachowski
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

Review 8.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

9.  Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.

Authors:  Brendan M Walker; George F Koob
Journal:  Neuropsychopharmacology       Date:  2007-05-02       Impact factor: 7.853

Review 10.  The kappa-opiate receptor impacts the pathophysiology and behavior of substance use.

Authors:  David Mysels; Maria A Sullivan
Journal:  Am J Addict       Date:  2009 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.